Search Results - "Milde, Till"
-
1
HDAC family: What are the cancer relevant targets?
Published in Cancer letters (08-05-2009)“…Abstract Histone deacetylases comprise a family of 18 genes, which are grouped into classes I–IV based on their homology to their respective yeast orthologues…”
Get full text
Journal Article -
2
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
Published in Acta neuropathologica (01-08-2018)“…Recently, we described a machine learning approach for classification of central nervous system tumors based on the analysis of genome-wide DNA methylation…”
Get full text
Journal Article -
3
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Published in Acta neuropathologica (01-06-2016)“…Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological variables pertaining to age, presence of metastases, extent…”
Get full text
Journal Article -
4
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
Published in Acta neuropathologica (01-06-2016)“…With the number of prognostic and predictive genetic markers in neuro-oncology steadily growing, the need for comprehensive molecular analysis of…”
Get full text
Journal Article -
5
Response to trametinib treatment in progressive pediatric low-grade glioma patients
Published in Journal of neuro-oncology (01-09-2020)“…Introduction A hallmark of pediatric low-grade glioma (pLGG) is aberrant signaling of the mitogen activated protein kinase (MAPK) pathway. Hence, inhibition of…”
Get full text
Journal Article -
6
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study
Published in Orphanet journal of rare diseases (03-05-2019)“…Tuberous sclerosis complex (TSC) is a multisystem disease with prominent neurologic manifestations such as epilepsy, cognitive impairment and autism spectrum…”
Get full text
Journal Article -
7
Histone deacetylase 10 promotes autophagy-mediated cell survival
Published in Proceedings of the National Academy of Sciences - PNAS (09-07-2013)“…Tumor cells activate autophagy in response to chemotherapy-induced DNA damage as a survival program to cope with metabolic stress. Here, we provide in vitro…”
Get full text
Journal Article -
8
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice
Published in Nature medicine (01-05-2010)“…Obsessive-compulsive disorder (OCD) is a common psychiatric disorder defined by the presence of obsessive thoughts and repetitive compulsive actions, and it…”
Get full text
Journal Article -
9
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
Published in Nature communications (20-09-2021)“…Long-term complications such as radiation-induced second malignancies occur in a subset of patients following radiation-therapy, particularly relevant in…”
Get full text
Journal Article -
10
HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
Published in Clinical cancer research (15-06-2010)“…Medulloblastomas are the most common malignant brain tumors in childhood. Survivors suffer from high morbidity because of therapy-related side effects. Thus,…”
Get full text
Journal Article -
11
Molecular Staging of Intracranial Ependymoma in Children and Adults
Published in Journal of clinical oncology (01-07-2010)“…The biologic behavior of intracranial ependymoma is unpredictable on the basis of current staging approaches. We aimed at the identification of recurrent…”
Get full text
Journal Article -
12
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions
Published in Acta neuropathologica (01-11-2019)“…Molecular markers have become pivotal in brain tumor diagnostics. Mutational analyses by targeted next-generation sequencing of DNA and array-based DNA…”
Get full text
Journal Article -
13
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Published in Acta neuropathologica (01-12-2021)Get full text
Journal Article -
14
Predisposition to cancer in children and adolescents
Published in The lancet child & adolescent health (01-02-2021)“…Childhood malignancies are rarely related to known environmental exposures, and it has become increasingly evident that inherited genetic factors play a…”
Get more information
Journal Article -
15
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
Published in Journal of neuro-oncology (01-11-2021)“…Purpose Survival in recurrent ependymoma (EPN) depends mainly on the extent of resection achieved. When complete resection is not feasible, chemotherapy is…”
Get full text
Journal Article -
16
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
Published in Nucleic acids research (01-07-2013)“…MYCN is a master regulator controlling many processes necessary for tumor cell survival. Here, we unravel a microRNA network that causes tumor suppressive…”
Get full text
Journal Article -
17
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Published in Journal of hematology and oncology (29-04-2024)“…Constitutional heterozygous pathogenic variants in genes coding for some components of the Fanconi anemia-BRCA signaling pathway, which repairs DNA interstrand…”
Get full text
Journal Article -
18
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Published in Pharmaceuticals (Basel, Switzerland) (27-10-2020)“…The survival rate among children with relapsed neuroblastomas continues to be poor, and thus new therapeutic approaches identified by reliable preclinical drug…”
Get full text
Journal Article -
19
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
Published in BMC cancer (05-06-2020)“…Pediatric patients with relapsed or refractory disease represent a population with a desperate medical need. The aim of the INFORM (INdividualized Therapy FOr…”
Get full text
Journal Article -
20
Group-specific cellular metabolism in Medulloblastoma
Published in Journal of translational medicine (05-06-2023)“…Cancer metabolism influences multiple aspects of tumorigenesis and causes diversity across malignancies. Although comprehensive research has extended our…”
Get full text
Journal Article